Орел Надежда Федоровна
Russian Cancer Research Center NN Blokhin · 77 works · 87 citations · h-index 3
Top works
- Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases
- Esthesioneuroblastoma: clinical course, long-term results of treatment
- Somatostatin receptor type 2 expression in Merkel cell carcinoma as a prognostic factor
- THE COMPARISON OF THE THERAPEUTIC EQUIVALENCE OF OXALIPLATINRONC® (BRANCH “NAUKOPROFI” OF N.N. BLOKHIN RCRC) AND ELOXATIN® (AVENTIS PHARMA LTD, GREAT BRITAIN) IN MFOLFOX6 COMBINATION AS A FIRST LINE OF CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
- Long Acting Octreotide in PTS with Disseminated Neuroendocrine Tumors
- WHICH PATIENTS WITH OVARIAN CANCER SHOWS THE COMBINATION OF TRABECTEDIN WITH PEGYLATED LIPOSOMAL DOXORUBICIN
- Практические рекомендации по лекарственному лечению нейроэндокринных опухолей желудочно-кишечного тракта, поджелудочной железы и других локализаций
- SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT
- [Aranoza -- a new Russian antineoplastic drug].
- Cancer patient management during the COVID-19 pandemic Training module. Version 2 from 30.04.2020
- Hospital registry of neuroendocrine tumors in N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation
- Практические рекомендации по лекарственному лечению нейроэндокринных неоплазий лёгких и тимуса
- Практические рекомендации по лекарственному лечению нейроэндокринных неоплазий желудочно-кишечного тракта, поджелудочной железы и других локализаций
- Практические рекомендации по лекарственному лечению нейроэндокринных неоплазий желудочно-кишечного тракта и поджелудочной железы
- [Comparative pharmaco-economic analysis of docetaxel with cisplatin and cyclophosphamide with cisplatin in first-line chemotherapy of advanced ovarian cancer].
- SUCCESSFUL TREATMENT OF SQUAMOUS-CELL RECTAL CANCER: А CASE REPORT
- Vozmozhnosti targetnoy terapiipri lechenii neyroendokrinnykhopukholey zheludochno-kishechnogotrakta i podzheludochnoy zhelezy
- PROGNOSTIC FACTORS OF THE EFFICACY OF ARANOZA-BAZED THERAPY IN NEUROENDOCRINE NEOPLASMS
- PERSPECTIVES ON USE OF BEVACIZUMAB IN PATIENTS WITH NEUROENDOCRINE TUMORS. CASE REPORT
- 216 Second-line treatment regimen in patients with limited small cell lung cancer (SCLC)